Viewing Study NCT05763992


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2025-12-28 @ 4:09 PM
Study NCT ID: NCT05763992
Status: RECRUITING
Last Update Posted: 2023-05-18
First Post: 2023-01-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module